Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | INSM | RPRX | ||
| Company | Biogen Inc | Insmed Inc | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 185.42 | 170.00 | 40.26 | ||
| High | 186.32 | 170.45 | 40.49 | ||
| Low | 177.05 | 162.30 | 39.87 | ||
| Latest | 178.30 | 163.72 | 40.36 | ||
| Change | -7.33 | -4.00 | +0.10 | ||
| % Change | -3.95% | -2.38% | +0.25% | ||
| Volume | 1,597,300 | 3,741,500 | 4,907,300 | ||
| 20-Day Average Volume | 2,244,750 | 4,046,125 | 3,575,660 | ||
| Previous Close | 185.63 | 167.72 | 40.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 177.79 | 177.54 | 39.36 | ||
| 20-Day Raw Stochastic | 45.01% | 6.10% | 65.37% | ||
| 20-Day Relative Strength | 53.85 | 38.05 | 57.93 | ||
| Weighted Alpha | +35.95 | +96.82 | +31.27 | ||
| Today's Opinion | 100% Buy | 24% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.36% since 01/06/26 | -6.48% since 01/06/26 | -0.71% since 01/06/26 | ||
| Low | 177.05 on 01/13/26 | 162.30 on 01/13/26 | 39.87 on 01/13/26 | ||
| High | 190.20 on 01/09/26 | 186.19 on 01/09/26 | 41.70 on 01/08/26 | ||
| 1-Month | |||||
| %Chg | +2.41% since 12/12/25 | -16.90% since 12/12/25 | +5.13% since 12/12/25 | ||
| Low | 168.56 on 12/18/25 | 161.02 on 12/18/25 | 37.83 on 12/16/25 | ||
| High | 190.20 on 01/09/26 | 205.23 on 12/17/25 | 41.70 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +23.23% since 10/13/25 | -0.13% since 10/13/25 | +13.88% since 10/13/25 | ||
| Low | 138.00 on 10/30/25 | 154.79 on 10/23/25 | 35.50 on 10/14/25 | ||
| High | 190.20 on 01/09/26 | 212.75 on 12/02/25 | 41.70 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +32.85% since 07/11/25 | +66.75% since 07/11/25 | +12.61% since 07/11/25 | ||
| Low | 121.05 on 07/21/25 | 97.34 on 07/14/25 | 34.08 on 09/08/25 | ||
| High | 190.20 on 01/09/26 | 212.75 on 12/02/25 | 41.70 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,232,292 | 35,770,148 | 23,239,600 | ||
| Shares Outstanding, K | 146,702 | 213,273 | 577,238 | ||
| Annual Sales | 9,675,900,000 | 363,710,000 | 2,263,580,000 | ||
| Annual Net Income | 1,632,200,000 | -913,770,000 | 858,980,000 | ||
| Last Quarter Sales | 2,534,700,000 | 142,340,000 | 609,290,000 | ||
| Last Quarter Net Income | 466,500,000 | -370,020,000 | 288,220,000 | ||
| 60-Month Beta | 0.13 | 1.08 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.81 on 10/30/25 | -1.75 on 10/30/25 | 1.17 on 11/05/25 | ||
| Latest Earnings Date | 02/11/26 | 02/19/26 | 02/10/26 | ||
| Most Recent Dividend | N/A | N/A | 0.220 on 11/14/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 11.21 | 0.00 | 8.89 | ||